| Clinical use of dendritic cells for cancer therapy S Anguille, EL Smits, E Lion, VF van Tendeloo, ZN Berneman The lancet oncology 15 (7), e257-e267, 2014 | 774 | 2014 |
| Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination VF Van Tendeloo, A Van de Velde, A Van Driessche, N Cools, S Anguille, ... Proceedings of the National Academy of Sciences 107 (31), 13824-13829, 2010 | 469 | 2010 |
| CD56 in the immune system: more than a marker for cytotoxicity? HH Van Acker, A Capsomidis, EL Smits, VF Van Tendeloo Frontiers in immunology 8, 892, 2017 | 360 | 2017 |
| The potential and controversy of targeting STAT family members in cancer Y Verhoeven, S Tilborghs, J Jacobs, J De Waele, D Quatannens, ... Seminars in cancer biology 60, 41-56, 2020 | 296 | 2020 |
| The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy ELJM Smits, P Ponsaerts, ZN Berneman, VFI Van Tendeloo The oncologist 13 (8), 859-875, 2008 | 269 | 2008 |
| Non‐thermal plasma as a unique delivery system of short‐lived reactive oxygen and nitrogen species for immunogenic cell death in melanoma cells A Lin, Y Gorbanev, J De Backer, J Van Loenhout, W Van Boxem, ... Advanced Science 6 (6), 1802062, 2019 | 211 | 2019 |
| Bisphosphonates for cancer treatment: mechanisms of action and lessons from clinical trials HH Van Acker, S Anguille, Y Willemen, EL Smits, VF Van Tendeloo Pharmacology & therapeutics 158, 24-40, 2016 | 211 | 2016 |
| Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia S Anguille, AL Van de Velde, EL Smits, VF Van Tendeloo, G Juliusson, ... Blood, The Journal of the American Society of Hematology 130 (15), 1713-1721, 2017 | 208 | 2017 |
| Poly (I: C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs R Ammi, J De Waele, Y Willemen, I Van Brussel, DM Schrijvers, E Lion, ... Pharmacology & therapeutics 146, 120-131, 2015 | 205 | 2015 |
| CD70: An emerging target in cancer immunotherapy J Jacobs, V Deschoolmeester, K Zwaenepoel, C Rolfo, K Silence, ... Pharmacology & therapeutics 155, 1-10, 2015 | 191 | 2015 |
| Dendritic cells as pharmacological tools for cancer immunotherapy S Anguille, EL Smits, C Bryant, HH Van Acker, H Goossens, E Lion, ... Pharmacological reviews 67 (4), 731-753, 2015 | 178 | 2015 |
| Natural killer cell immune escape in acute myeloid leukemia E Lion, Y Willemen, ZN Berneman, VFI Van Tendeloo, ELJ Smits Leukemia 26 (9), 2019-2026, 2012 | 171 | 2012 |
| RNA-based gene transfer for adult stem cells and T cells E Smits, P Ponsaerts, M Lenjou, G Nijs, DR Van Bockstaele, ... Leukemia 18 (11), 1898-1902, 2004 | 147 | 2004 |
| Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections B Ogunjimi, SY Zhang, KB Sørensen, KA Skipper, M Carter-Timofte, ... The Journal of clinical investigation 127 (9), 3543-3556, 2017 | 132 | 2017 |
| Anti-cancer capacity of plasma-treated PBS: Effect of chemical composition on cancer cell cytotoxicity W Van Boxem, J Van der Paal, Y Gorbanev, S Vanuytsel, E Smits, ... Scientific reports 7 (1), 1-15, 2017 | 131 | 2017 |
| Interferon-α in acute myeloid leukemia: an old drug revisited S Anguille, E Lion, Y Willemen, VFI Van Tendeloo, ZN Berneman, E Smits Leukemia 25 (5), 739-748, 2011 | 127 | 2011 |
| Immunosuppression induced by immature dendritic cells is mediated by TGF‐β/IL‐10 double‐positive CD4+ regulatory T cells N Cools, VFI Van Tendeloo, E Smits, M Lenjou, G Nijs, ... Journal of cellular and molecular medicine 12 (2), 690-700, 2008 | 121 | 2008 |
| Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells HH Van Acker, S Anguille, Y Willemen, JM Van den Bergh, ZN Berneman, ... Journal of hematology & oncology 9, 1-13, 2016 | 117 | 2016 |
| mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients E Van Gulck, E Vlieghe, M Vekemans, VFI Van Tendeloo, A Van De Velde, ... Aids 26 (4), F1-F12, 2012 | 116 | 2012 |
| Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties S Anguille, ELJM Smits, N Cools, H Goossens, ZN Berneman, ... Journal of translational medicine 7, 1-16, 2009 | 116 | 2009 |
